MIR1538: A Potential Drug Target and Biomarker (G100302119)
MIR1538: A Potential Drug Target and Biomarker
MIR1538, a protein encoded by the gene IDH1, is a key regulator of the microtubule network and a potential drug target in cancer. It plays a crucial role in the maintenance of the integrity of the mitotic spindle, which is a critical structure that organizes the chromosomes during cell division. MIR1538 has been shown to promote the formation of mitotic spindles and to regulate the stability of microtubules.
Recent studies have identified MIR1538 as a potential drug target in cancer. MIR1538 has been shown to be highly expressed in various types of cancer, including breast, ovarian, and colorectal cancer. It has also been shown to be involved in the regulation of cell cycle progression and in the maintenance of the mitotic spindle. Therefore, MIR1538 may be an attractive target for cancer therapies that aim to inhibit cell division or disrupt the mitotic spindle.
In addition to its potential as a drug target, MIR1538 has also been identified as a potential biomarker for cancer. Its expression has been shown to be associated with the development and progression of various types of cancer. For example, MIR1538 has been shown to be highly expressed in breast cancer and has been shown to contribute to the progression of breast cancer in both humans and animals.
The identification of MIR1538 as a potential drug target and biomarker makes it an important area of research for cancer scientists. Further studies are needed to determine the full extent of its potential as a drug target and to understand its role as a biomarker in cancer.
In conclusion, MIR1538 is a protein that has the potential to be a drug target and biomarker in cancer. Further studies are needed to fully understand its role in cancer and to develop effective therapies that target it.
Protein Name: MicroRNA 1538
The "MIR1538 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1538 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B
